First Mercantile Trust’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,158	Closed	-$134K	–	869
2020 Q1	$134K	Buy	3,158 +1,273	+68%	+$54K	0.02%	467
2019 Q4	$115K	Buy	+1,885	New	+$115K	0.01%	642
2018 Q3	–	Sell	-2,401	Closed	-$141K	–	919
2018 Q2	$141K	Buy	+2,401	New	+$141K	0.03%	616